4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-051435
Chief Scientific Officer sold 2,146 shares at $61.99 ($133,031)
- Chief Scientific Officer acquired 2,146 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2017-09-01 | Option exercise | +2,146 | $9.05 | $19,421 | 8,410 | D: show line 1 in the form |
| Biller Scott Chief Scientific Officer | 2017-09-01 | Sale | −2,146 | $61.99 | $133,031 | 6,264 | D: show line 2 in the form |
| Open-market sales · 2,146 sh · avg $61.99 · $133,031 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2017-09-01 | Option exercise · Stock option (right to buy) | −2,146 | 35,281 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…